Medical equipment maker Danaher Corp has expressed interest in taking over contract drugmaker Catalent Inc, Bloomberg News reported on Saturday, citing people familiar with the matter.

Orpea SA announced a financial restructuring on Wednesday giving bondholders the lion's share of control as the French nursing care provider looks to recover after charges of malpractice at its homes.

Private equity firm KKR & Co Inc told Reuters on Tuesday it will invest up to $250 million in a new company led by industrial sector veterans to acquire and build businesses, with a focus on the testing, inspection and certification sectors. Andrew Silvernail, a former chief executive of pump manufacturer IDEX Corp, will serve as chairman of the new venture, while Amit Agarwal, a former Thermo Fisher Scientic Inc vice president, will serve as its chief executive. The

France's public lender, Caisse des Depots et Consignations (CDC), has reached an agreement with Orpea's creditors to take over the indebted nursing home group, a French newspaper reported on Tuesday.

Pharmacy chain Walgreens Boots Alliance Inc is weighing a sale of its pharmacy automation business, which could fetch up to $2 billion, Bloomberg News reported on Wednesday citing people familiar with the matter.

Walgreens Boots Alliance Inc is weighing a sale of its pharmacy automation business, which could fetch up to $2 billion, Bloomberg News reported on Wednesday citing people familiar with the matter. (Reporting by Sriparna Roy in Bengaluru; Editing by Krishna Chandra Eluri)

Hong Kong-based multinational Li & Fung Ltd is considering options for its Asian healthcare arm, including a sale, that could value the business at up to $500 million, two people with direct knowledge of the matter told Reuters.

U.S. life sciences company Illumina is likely to face a fine of 10% of its global annual turnover, the maximum penalty, for closing its takeover of Grail without waiting for EU antitrust approval, people familiar with the matter said.

U.S. life sciences company Illumina on Tuesday challenged an EU antitrust order to keep biotech firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year.

U.S. life sciences company Illumina on Tuesday challenged an EU antitrust order to keep biotech firm Grail separate, ratcheting up its fight against EU regulators which blocked a merger deal last year.